Stockscreener 앱 받기
1.95
1.04%
0.02
전일 마감가:
$1.93
열려 있는:
$1.92
하루 거래량:
30,488
Relative Volume:
0.29
시가총액:
$88.63M
수익:
$134.00K
순이익/손실:
$-9.93M
주가수익비율:
-5.7353
EPS:
-0.34
순현금흐름:
$-6.72M
1주 성능:
+4.84%
1개월 성능:
+4.84%
6개월 성능:
-10.96%
1년 성능:
+21.12%
1일 변동 폭
$1.9153
$1.98
1주일 범위
$1.9153
$2.35
52주 변동 폭
$1.41
$2.79
Entera Bio Ltd Stock (ENTX) Company Profile
명칭
Entera Bio Ltd
전화
972-2-532-7151
주소
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
ENTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENTX
Entera Bio Ltd
|
1.95 | 87.72M | 134.00K | -9.93M | -6.72M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-22 | 개시 | Aegis Capital | Buy |
Entera Bio Ltd 주식(ENTX)의 최신 뉴스
What makes Entera Bio Ltd. stock price move sharplyFree Community Verified Stock Suggestions - Newser
Multi factor analysis applied to Entera Bio Ltd.Breakout Monitoring with Momentum Analysis - Newser
Sentiment analysis tools applied to Entera Bio Ltd.Stock Portfolio Risk and Return Analysis - Newser
Is Entera Bio Ltd. a growth stock or a value stockLow Risk Updates For Beginners - jammulinksnews.com
How Entera Bio Ltd. stock performs during market volatilityProfitable Trading Blueprint with Entry Zones - Newser
How to forecast Entera Bio Ltd. trends using time seriesBear Market Safe Zone Technical Analysis - Newser
What are analysts’ price targets for Entera Bio Ltd. in the next 12 monthsValue Investing Tracker To Watch Now - jammulinksnews.com
Entera Bio (ENTX) Projected to Post Earnings on Friday - Defense World
When is the best time to buy Entera Bio Ltd. stockHigh Return Trade Roadmap with Setup Filters - Newser
How volatile is Entera Bio Ltd. stock compared to the marketBest Dividend Tracker For Every Investor - jammulinksnews.com
Why Entera Bio Ltd. stock attracts strong analyst attentionBuy Signal Forecast With Short-Term Data - Newser
How strong is Entera Bio Ltd. company’s balance sheetReal Time Signals For Consistent Profits - jammulinksnews.com
Entera Bio Ltd. Stock (ENTX) Opinions on FDA Agreement for EB613 Endpoint - Quiver Quantitative
How did ENTX's revenue and expenses trend in Q4 2024? - AInvest
Is Entera Bio Ltd. stock reversal real or fakeEntry Zone Forecast for Momentum Trading - Newser
Entera Bio (NASDAQ:ENTX) Trading Up 10.8% – What’s Next? - Defense World
Entera Bio Receives FDA Agreement on BMD as Primary - GlobeNewswire
Entera Bio Ltd. Recovery Hinges on Volume BreakoutFast Entry High Potential Stock Alerts Triggered - metal.it
What is the dividend policy of Entera Bio Ltd. stockDiscover investment plans that deliver results - jammulinksnews.com
Entera Bio stock surges after FDA agrees on BMD endpoint for EB613 By Investing.com - Investing.com South Africa
Entera Bio stock surges after FDA agrees on BMD endpoint for EB613 - Investing.com Nigeria
FDA agrees to BMD endpoint for Entera’s oral osteoporosis drug By Investing.com - Investing.com South Africa
Entera Bio Advances EB613 with FDA Approval - TipRanks
FDA Agrees to BMD Endpoint for First Oral Osteoporosis Drug Phase 3 Trial | ENTX Stock News - Stock Titan
Is it the right time to buy Entera Bio Ltd. stockHigh-profit stock alerts - jammulinksnews.com
What is Entera Bio Ltd. company’s growth strategyDiscover stocks with explosive upside potential - jammulinksnews.com
How does Entera Bio Ltd. compare to its industry peersRapid-fire capital growth - jammulinksnews.com
Does Entera Bio Ltd. stock perform well during market downturnsStay ahead with daily market updates - jammulinksnews.com
When is Entera Bio Ltd. stock expected to show significant growthFree Stock Selection - jammulinksnews.com
Entera Bio Ltd. Stock Analysis and ForecastGame-changing capital returns - PrintWeekIndia
Entera Bio Ltd (ENTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.15%
자본화:
|
볼륨(24시간):